Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2025-12-25 @ 12:00 AM
NCT ID: NCT06612658
Eligibility Criteria: Inclusion Criteria: 1. Male subjects aged between 18-35 years (both limits inclusive). 2. Subjects must have a BMI of 18.5 to 29.9 kg/m2 (both limits inclusive) 3. Subjects must have greater than one year of resistance training experience at a frequency of 2 days per week. 4. Subjects must be proficient in the barbell back squat exercise. 5. Subjects must be free of any physical limitations or chronic illness that may affect performance. 6. Subjects must be free of any medications. 7. Subjects who agree to refrain from consuming alcohol 24 hours prior to the visit days. 8. Subjects who agreed to refrain from consuming caffeine and caffeine-containing products 12 hour prior to visit days 9. Subject willing to provide written consent. Exclusion Criteria: 1. Subjects who have hypersensitivity or history of allergy to the study product. 2. Subjects with inability to swallow soft gel capsules. 3. Subjects with any other medical condition that might adversely impact the safety of the study participants or confound the study results. 4. Subjects who require medications. 5. Subjects who regularly use a dietary supplement containing Capsimax or other ingredients that would impact study endpoints. 6. Subjects who had been treated with any investigational drug or investigational device within a period of 3 months prior to study entry
Healthy Volunteers: False
Sex: MALE
Minimum Age: 18 Years
Maximum Age: 35 Years
Study: NCT06612658
Study Brief:
Protocol Section: NCT06612658